January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For example, health tech companies like Medtronic and athenahealth hired new C-suite leaders, and providers like Cleveland Clinic and Jefferson Health announced rounds of job cuts. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first…
LOS ÁNGELES, CA — Mia Angulo, que está embarazada y dará a luz en mayo, vive en una tienda de campaña con su novio en el vecindario predominantemente latino de Boyle Heights. El dolor persistente por un accidente de auto ocurrido hace dos meses, sumado a una vida ya difícil, tiene a Angulo preocupada por…
KFF Health News chief Washington correspondent Julie Rovner discussed funding cuts at the Department of Health and Human Services on CBS News’ “24/7” on May 7. Click here to watch Rovner on “24/7.” Listen to this week’s episode of “What the Health?” — hosted by Rovner: “Cutting Medicaid Is Hard — Even for the GOP.”…
Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller. The post Roche’s Metabolic…
Draft Continuing Resolution released on March 8 includes an extension of the telehealth flexibilities through September 30
Proposals from some Republicans in Congress would effectively repeal some or all of the ACA premium tax credits and replace them with contributions to Health Savings Accounts (HSAs) or something similar. Senator Rick Scott proposes “Trump Health Freedom Accounts” and Senator Bill Cassidy proposes HSA contributions available only for people who enroll in bronze level…
Regulus Therapeutics drug farabursen is a potential first-in-class treatment for a rare kidney disease whose only FDA-approved therapy introduces severe toxicity risks. Farabursen is joining a Novartis drug lineup spanning several therapies for rare renal disorders. The post Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition appeared first on MedCity News.
Here are five things providers should know about concussions. The post Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate appeared first on MedCity News.
By DEEKSHA HEGDE How to spot a fundamental business model shift from a mile away, long before the PR calls it a product launch or market expansion. In April 2026, Progyny, a fertility and family building benefits administrator, announced Progyny Select, a supplemental health plan for small and mid-size employers (100-1,000 employees). “Pooled-risk” got me…
This issue brief provides an update on the status of the Trump administration’s actions to eliminate DEI-related initiatives and the impact on racial health disparities.